This article has Open Peer Review reports available.
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
© Bailey et al; licensee BioMed Central Ltd. 2013
Received: 31 October 2012
Accepted: 20 February 2013
Published: 20 February 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|31 Oct 2012||Submitted||Original manuscript|
|6 Dec 2012||Reviewed||Reviewer Report - Gérard Slama|
|7 Dec 2012||Reviewed||Reviewer Report - Bob Ryder|
|10 Dec 2012||Author responded||Author comments - Clifford Bailey|
|Resubmission - Version 2|
|10 Dec 2012||Submitted||Manuscript version 2|
|16 Jan 2013||Author responded||Author comments - Clifford Bailey|
|Resubmission - Version 3|
|16 Jan 2013||Submitted||Manuscript version 3|
|20 Feb 2013||Editorially accepted|
|20 Feb 2013||Article published||10.1186/1741-7015-11-43|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.